Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Rural health sign | Image credit: BJP7images - stock.adobe.com
FQHCs Show Low Engagement in Hypertension, Diabetes Trials

April 15th 2025

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com
Housing Instability Linked to Worse Type 2 Diabetes Outcomes

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

AJMC
The Role of Advanced Technologies in Improving Diabetes Outcomes

April 7th 2025

Diabetes - Vitalii Vodolazskyi - stock.adobe.com.jpg
More Than 250 Million Individuals Unaware They Have Diabetes

April 7th 2025

More News

Jill Hutt
March 25th 2022

Jill Hutt Outlines the Impact of COVID-19 on Diabetes Prevention Efforts

Gianna Melillo
Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the importance of offering the Diabetes Prevention Program online.
roads and cross walks
March 22nd 2022

Walkability and Redlining: How Built Environments Impact Health and Perpetuate Disparities

Gianna Melillo
Built environments can shape how active an individual is, while policy decisions made decades ago impact health disparities today. To address these critical social determinants of health, experts are calling for increased cooperation between urban planners and the public health field.
clock
March 17th 2022

Food Consumption Timing Could Impact CVD Mortality Risk in Diabetes

Gianna Melillo
Superior long-term survival was seen among patients with diabetes who ate potatoes in the morning, whole grains in the afternoon, and greens and milk in the evening, according to new study results.
Jill Hutt
March 15th 2022

Jill Hutt Describes the Importance of Addressing Prediabetes

Gianna Melillo
Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), explains why it is cost effective for employers to address employees' prediabetes.
Site Logo
March 8th 2022

Diabetes Care Quality: Do Large Medical Groups Perform Better?

Leif I. Solberg, MD Caroline S. Carlin, PhD Kevin A. Peterson, MD, MPH Milton Eder, PhD
Large medical groups perform better than medium- or small-sized groups on diabetes quality measures, perhaps because they have more care management processes in place.
Jill Hutt
March 7th 2022

Jill Hutt on How Employers Encourage DPP Participation

Gianna Melillo
Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), discusses different ways employers motivate employees to partake in the Diabetes Prevention Program (DPP).
liver icon
March 3rd 2022

NAFLD Linked With Increased Risk of Hypoglycemia in T2D, Independent of Obesity Status

Gianna Melillo
New data revealed that among patients with type 2 diabetes (T2D), presence of nonalcoholic fatty liver disease (NAFLD) may raise the risk of severe hypoglycemia episodes.
Jill Hutt
February 28th 2022

Jill Hutt Explains Wilmington, DE's Success With the DPP

Gianna Melillo
Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), outlines how Wilmington, Delaware, went about implementing the Diabetes Prevention Program.
FDA Approves Empagliflozin for Broader Type of Heart Failure
February 24th 2022

FDA Approves Empagliflozin for Broader Type of Heart Failure

Gianna Melillo
Jardiance (empagliflozin) received approval from the FDA for a new indication to treat heart failure in a broader range of patients, including those with preserved ejection fraction.
Jill Hutt
February 23rd 2022

Jill Hutt Outlines the GPBCH's Work With the National Diabetes Prevention Program

Gianna Melillo
Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health (GPBCH), describes how the organization first became involved with the National Diabetes Prevention Program.
stethoscope on US flag
February 14th 2022

NCCC Releases Recommendations to Improve Federal Response to Diabetes Epidemic

Gianna Melillo
The National Clinical Care Commission (NCCC) issued 39 recommendations to improve diabetes prevention and care in the United States.
Calum Yacoubian, MD
February 13th 2022

Contributor: How Payers Are Applying AI to Solve the Problem of Incomplete Data—3 Use Cases

Calum Yacoubian, MD
In this column, Calum Yacoubian, MD, outlines how artificial intelligence, specifically, natural language processing, can help address gaps in patient data.
Robert Gabbay, MD, PhD
February 11th 2022

Dr Robert Gabbay on the Intersection of COVID-19 and Diabetes

Gianna Melillo Skylar Jeremias
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, shares his thoughts on long COVID-19 among those with type 2 diabetes and the rise of new-onset cases of type 1 diabetes throughout the pandemic.
syringe and vial
February 8th 2022

SURPASS-5 Data: Tirzepatide Plus Insulin Glargine Improve Glycemic Control in T2D

Gianna Melillo
Data from SURPASS-5 show Eli Lilly's glucagon-like peptide-1 receptor agonist tirzepatide helped improve glycemic control when taken with insulin glargine.
Robert Gabbay, MD, PhD
February 2nd 2022

Dr Robert Gabbay Discusses Management of Pediatric Type 1, 2 Diabetes

Gianna Melillo Skylar Jeremias
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses some of the challenges of treating pediatric patients with type 1 or type 2 diabetes.
fda logo
January 31st 2022

Insulet's Omnipod 5 Cleared by FDA

Gianna Melillo
The FDA has cleared the first tubeless automated insulin delivery system with a smartphone app control.
health graphic
January 25th 2022

Increases in Pediatric T1D Incidence Seen During COVID-19

Gianna Melillo
Findings from 2 studies conducted among German and US children highlight the growing incidence of type 1 diabetes (T1D) among children throughout the COVID-19 pandemic.
Liver illustration
January 23rd 2022

Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD

Juan Pablo Frias, MD
In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.
diabetes graphic
January 19th 2022

SDOH-Induced Changes to Gut Microbiome Could Contribute to Racial Disparities in T2D

Gianna Melillo
Findings of a pilot study suggest that gut microbiome differences resulting from environmental factors could affect racial disparities in type 2 diabetes.
pills spread over bills
January 17th 2022

Diabetes Medication Costs, Utilization Differed by Medicaid or Marketplace Enrollment

Gianna Melillo
New data show that Medicaid enrollees with diabetes in Colorado have greater access to new medications and incur less associated costs compared with patients with Marketplace plans.
world image
January 12th 2022

Decrease in Diabetes All-Cause Mortality Seen in High-Income Countries

Gianna Melillo
New data revealed that rates of all-cause mortality among those with diabetes decreased between 1995 and 2016 in high-income countries.
Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System
January 10th 2022

Researchers Propose Model to Replicate Patient Experience in Artificial Pancreas System

Lauren Massaro
A methodology to monitor patient-in-the-loop modes and faults was examined using a hybrid automata model that was able to replicate patient’s real-life operation modes.
technology image
January 8th 2022

Review: Commercially Developed, Open-Source AID Systems Deemed Safe and Effective

Lauren Massaro Gianna Melillo
Gleaning data from real-world studies, investigators determined that commercially developed and open-source automated insulin dosing systems are safe and effective.
USA graphic
January 5th 2022

Study Supports Call for Geographically Tailored Diabetes Care Interventions

Gianna Melillo
Patients with diabetes living in rural or deprived regions in the United States are less likely to achieve optimal care for their condition, according to a new cross-sectional study.
t1d graphic
December 30th 2021

Top 5 Most-Read Type 1 Diabetes Articles of 2021

Gianna Melillo
The most popular type 1 diabetes articles published in 2021 included new research on screening and updated coverage policy.
stethoscope on US flag
December 27th 2021

Analysis Highlights Disparities in GLP-1 RA Access

Gianna Melillo
An analysis uncovered racial, ethnic, and socioeconomic inequities regarding access to glucagon-like peptide-1 receptor agonists among US patients with diabetes.
blue cross
December 23rd 2021

Family History of T2D May Increase MACE Risk in Those With T1D

Gianna Melillo
A study carried out in Taiwan found that a family history of type 2 diabetes (T2D) may increase the risks of diabetes-related complications in those with type 1 diabetes (T1D).
diabetes graphic
December 20th 2021

Top 5 Most-Read Diabetes Articles of 2021

Gianna Melillo
New research on semaglutide and empagliflozin appear on this year’s list of most-read diabetes articles.
diversity graphic
December 15th 2021

Study: Racial-Ethnic Disparities in T1D Technology Use Worsened From 2017 to 2019

Gianna Melillo
Between coverage years 2017 and 2019, racial-ethnic disparities in diabetes technology use worsened among Medicare beneficiaries with type 1 diabetes.
eye graphic
December 8th 2021

Experts Examine the Association Between Retinal Damage, DKD Presence in Patients With T2D

Gianna Melillo
Results of a cross-sectional study fond diabetic kidney disease (DKD) was associated with retinal changes in patients with type 2 diabetes (T2D).
<1
...
5678910111213
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo